- Home
- CCCC vs ATOM Comparison
CCCC vs ATOM Comparison
Compare CCCC & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- ATOM
- Stock Information
- Founded
- CCCC 2015
- ATOM 2001
- Country
- CCCC United States
- ATOM United States
- Employees
- CCCC N/A
- ATOM N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- ATOM Semiconductors
- Sector
- CCCC Health Care
- ATOM Technology
- Exchange
- CCCC Nasdaq
- ATOM Nasdaq
- Market Cap
- CCCC 244.9M
- ATOM 247.5M
- IPO Year
- CCCC 2020
- ATOM 2016
- Fundamental
- Price
- CCCC $3.64
- ATOM $9.41
- Analyst Decision
- CCCC Buy
- ATOM Strong Buy
- Analyst Count
- CCCC 6
- ATOM 1
- Target Price
- CCCC $10.67
- ATOM $7.00
- AVG Volume (30 Days)
- CCCC 1.9M
- ATOM 1.1M
- Earning Date
- CCCC 02-20-2025
- ATOM 02-11-2025
- Dividend Yield
- CCCC N/A
- ATOM N/A
- EPS Growth
- CCCC N/A
- ATOM N/A
- EPS
- CCCC N/A
- ATOM N/A
- Revenue
- CCCC $33,668,000.00
- ATOM $662,000.00
- Revenue This Year
- CCCC $75.79
- ATOM N/A
- Revenue Next Year
- CCCC N/A
- ATOM $2,800.00
- P/E Ratio
- CCCC N/A
- ATOM N/A
- Revenue Growth
- CCCC 65.45
- ATOM 13140.00
- 52 Week Low
- CCCC $3.25
- ATOM $2.31
- 52 Week High
- CCCC $11.88
- ATOM $17.55
- Technical
- Relative Strength Index (RSI)
- CCCC 41.72
- ATOM 46.13
- Support Level
- CCCC $3.25
- ATOM $7.87
- Resistance Level
- CCCC $3.84
- ATOM $9.25
- Average True Range (ATR)
- CCCC 0.20
- ATOM 1.22
- MACD
- CCCC -0.01
- ATOM -0.27
- Stochastic Oscillator
- CCCC 29.49
- ATOM 22.83
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the most widely used transistor type in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, FinFET technology, logic and processors, and SRAM.